Pfizer (PFE) — insider trading
Health Care · NYSE
Pfizer (PFE) has 41 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases and 2 open-market sales among the most recent 41 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 21 | $28.52 | $599 | Form 4 |
| 2026-09-25 | Quincey James | Director | Grant / award / vesting (derivative) | 1,352 | $28.67 | $38.8K | Form 4 |
| 2026-09-25 | SMITH JAMES C | Director | Grant / award / vesting (derivative) | 1,570 | $28.67 | $45.0K | Form 4 |
| 2026-09-25 | Taraporevala Cyrus | Director | Grant / award / vesting (derivative) | 1,308 | $28.67 | $37.5K | Form 4 |
| 2026-09-25 | NARAYEN SHANTANU | Director | Grant / award / vesting (derivative) | 1,744 | $28.67 | $50.0K | Form 4 |
| 2026-09-25 | Echevarria Joseph | Director | Grant / award / vesting (derivative) | 1,613 | $28.67 | $46.3K | Form 4 |
| 2026-09-25 | Buckley Mortimer J | Director | Grant / award / vesting (derivative) | 1,308 | $28.67 | $37.5K | Form 4 |
| 2026-09-15 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 22 | $27.55 | $606 | Form 4 |
| 2026-08-31 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 21 | $28.46 | $598 | Form 4 |
| 2026-08-14 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 22 | $26.79 | $589 | Form 4 |
| 2026-08-12 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Open-market purchase | 38,000 | $26.34 | $1.00M | Form 4 |
| 2026-08-05 | DAMICO JENNIFER B. | Officer (SVP & Controller) | Open-market sale | 3,278 | $25.40 | $83.3K | Form 4 |
| 2026-08-05 | Buckley Mortimer J | Director | Open-market purchase | 37,632 | $25.52 | $960.4K | Form 4 |
| 2026-08-05 | BLAYLOCK RONALD E | Director | Open-market purchase | 39,231 | $25.46 | $998.8K | Form 4 |
| 2026-07-31 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 24 | $25.01 | $600 | Form 4 |
| 2026-07-15 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 24 | $24.82 | $596 | Form 4 |
| 2026-07-09 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 84 | $24.25 | $2.0K | Form 4 |
| 2026-06-30 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 25 | $24.08 | $602 | Form 4 |
| 2026-06-26 | Taraporevala Cyrus | Director | Grant / award / vesting (derivative) | 1,544 | $24.29 | $37.5K | Form 4 |
| 2026-06-26 | Quincey James | Director | Grant / award / vesting (derivative) | 1,595 | $24.29 | $38.8K | Form 4 |
| 2026-06-26 | SMITH JAMES C | Director | Grant / award / vesting (derivative) | 1,853 | $24.29 | $45.0K | Form 4 |
| 2026-06-26 | NARAYEN SHANTANU | Director | Grant / award / vesting (derivative) | 2,058 | $24.29 | $50.0K | Form 4 |
| 2026-06-26 | Echevarria Joseph | Director | Grant / award / vesting (derivative) | 1,904 | $24.29 | $46.3K | Form 4 |
| 2026-06-26 | Buckley Mortimer J | Director | Grant / award / vesting (derivative) | 1,544 | $24.29 | $37.5K | Form 4 |
| 2026-06-15 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 23 | $26.00 | $598 | Form 4 |
| 2026-06-09 | DAMICO JENNIFER B. | Officer (SVP & Controller) | Open-market sale | 2,000 | $25.70 | $51.4K | Form 4 |
| 2026-05-29 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 23 | $26.18 | $602 | Form 4 |
| 2026-05-15 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 24 | $25.33 | $608 | Form 4 |
| 2026-04-30 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 22 | $26.70 | $587 | Form 4 |
| 2026-04-23 | Taraporevala Cyrus | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | SMITH JAMES C | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | Quincey James | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | NARAYEN SHANTANU | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | Echevarria Joseph | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | Desmond-Hellmann Susan | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | Buckley Mortimer J | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | BLAYLOCK RONALD E | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | LITTMAN DAN R. | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | NORA JOHNSON SUZANNE M | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-23 | Gottlieb Scott | Director | Grant / award / vesting (derivative) | 7,687 | $26.67 | $205.0K | Form 4 |
| 2026-04-15 | BOURLA ALBERT | Director, Officer (Chairman & CEO) | Grant / award / vesting (derivative) | 22 | $27.19 | $598 | Form 4 |
Ask the chat about PFE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Pfizer (PFE).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.